Princess Alexandra Hospitals NHS Trust Breast Unit Family History Clinic.

Slides:



Advertisements
Similar presentations
Collecting family history information This presentation can be used as part of Lesson Plan 3 Taking and Drawing a Family History. It can also be used with.
Advertisements

Breast cancer case study
What Do We Do? Cancer Genetics Service for Wales.
Hereditary GI Cancer Syndromes: Keys to identify high risk patients
Part Two Welcome back. Familial Cancer Genetics Cancer Genetics 5-10% of all cancer clearly linked to an inherited gene alteration If cancer seen at.
Which of the following increases a women’s risk for Breast Cancer? A.Starting her menses at age 14 or older B.Breastfeeding C.Extremely dense breast tissue.
Breast Cancer. Dr. Swapna Chaudhary M.S. (MUM) M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
 Introduction  Curriculum links and transferable skills  Cancer Syndromes › Breast/Ovarian Cancer › Colorectal Cancer  Cases  Patient Resources 
Genetics and genomics for healthcare © 2014 NHS National Genetics and Genomics Education Centre Why is genetics relevant to.
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
Level 8 - undergraduate students Breast cancer case study Enter resource.
Familial Cancer Risk Assessment: Breast and Ovarian Cancer Genetics and Primary Care.
Hereditary Factors in Breast Cancer
The Genetics of Breast and Ovarian Cancer Susceptibility Patricia Tonin, PhD Associate Professor Depts. Medicine, Human Genetics & Oncology McGill University.
Hereditary breast and ovarian cancer Who should be screened and How? Symposium on Cancer Waterloo Inn October 31, 2007 Mala Bahl, MD, MSc.
Genetics and Ovarian Cancer Jeanne M. Schilder, M.D. Associate Professor, Gynecologic Oncology Indiana University Medical Center September 19, 2012.
GenetiKit Workshop Given by: Dr. Sean Blaine, Family Physician Dr. June Carroll, Family Physician Clare Gibbons, Genetic Counsellor Cathy Gilpin, Genetic.
Hereditary Breast & Ovarian Cancer Syndrome HBOC Tammy McKamie RN MSN OCN Cancer Genetics Educator Clinical Oncology Patient Navigator.
Breast Cancer Risk and Risk Assessment Models
Genetics in Primary Care Dr. Jude Hayward GPwSI in Genetics Pennine HDR 31/3/09.
SURVIVORS TEACHING STUDENTS: SAVING WOMEN’S LIVES®
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Breast Cancer 2010 David B. Pearlstone, MD MBA FACS Co-Director, Breast Division John Theurer Cancer Center Chief, Division of Breast Surgery Hackensack.
Cancer Genetics for Primary Care Sara Levene Registered Genetic Counsellor.
Few more cases Cancer and cholesterol. Cancer and genetic testing Available guidance (NICE) Familial breast cancer /colonic/ovarian Familial Hypercholesteremia.
The Harvard Health Caucus Genetic Privacy: Legal & Ethical Frameworks Allan T. Bombard, MD, FACOG, FACS, FACMG Medical Director, Aetna Women’s Health Program.
OVARIAN CANCER Talking point: Genetics of ovarian cancer.
Cancer Genetics. Issues Colorectal guidelines – Awaiting publication of coloproctologists guidance – SIGN / QIS update started Breast / ovarian – Breast.
Breast Screening. NHS Breast Screening Programme Introduced in 1988 Invites women from age group for screening every 3 yrs. Age extension roll-out.
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
Genomics Alexandra Hayes. Genomics is the study of all the genes in a person, as well as the interactions of those genes with each other and a person’s.
SUMAYYA EBRAHIM GYNAECOLOGIST PARKLANE CLINIC JOHANNESBURG
Corrine Fillman, M.S., C.G.C. Connective Tissue Gene Tests (CTGT) 6580 Snowdrift Road, Suite 300 Allentown, PA
Level 9 – Degree Breast cancer case study Enter resource.
Breast Cancer Genetic Risk Communicating with Your Family Mary B. Daly, M.D., Ph.D. April 3, 2012.
Cancer Risk Assessment Judith A Westman MD Clinical Director Division of Human Genetics.
Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.
Clinical Utility of BRCA Testing Mark Robson, MD September 7,
Genetics and Cancer Sreekala Seepana. Overview Genetics and cancer Breast / Bowel cancers Breast / bowel cancer screening Clinical genetics referral Cases.
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
March 10, 2014 NURS 330 Human Reproductive Health.
Breast Ovarian Hereditary Breast & Ovarian Cancer Knowing one’s family medical history can be life-saving.
Genetics: For this Generation and the Next
SEXUAL HEALTH: SCREENING, VACCINES AND REFERRALS Dr Kate Morton.
Failure to appropriately screen women according to international guidelines– what are the consequences? Alison Johnston*, M Sugrue, S Curran Department.
Prostate Cancer There are roughly 240,000 cases of prostate cancer diagnosed in the United States each year, making it the most common cancer in males.
Two week rule for breast
Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital.
Consultant Obstetrician & Gynaecologist
Genomic Medicine Rebecca Tay Oncology Registrar. What is Genomic Medicine? personalised, precision or stratified medicine.
The National Cancer Research Network is part of the National Institute for Health Research CANCER GENETIC TRIALS Leicestershire, Northamptonshire and Rutland.
Date of download: 7/7/2016 From: Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review.
Refer to Beds & Herts Breast Cancer Family History Screening service
Kristen Zarfos, MD Linda Steinmark, MS, LCGC
Beaumont Hospital Breast Service
Introduction
Breast Cancer Screening/Imaging
Demystifying Cancer Genetics
Surgical Management of the Breast in Breast Cancer
FORM FOR REFERRING WOMEN WITH BREAST CANCER FOR GENETICS ASSESSMENT
BRCA1 and BRCA2 Cancer genetic counseling
Breast Screening and Risk Assessment
Who in the room would offer BRCA1/2 testing to this patient Who in the room would offer BRCA1/2 testing to this patient? How might the medical management.
Refer to Beds & Herts Breast Cancer Family History Screening service
Genetic Counseling & Testing for Cancer Risk
The decision tree with the two alternatives.
HBOC Genetic counseling: major concerns and communication skills
Diagnosis of breast cancer in women age 40 and younger: Delays in diagnosis result from underuse of genetic testing and breast imaging 95% of patients.
Breast Cancer BRCA testing protocol
Breast cancer BRCA testing protocol
Presentation transcript:

Princess Alexandra Hospitals NHS Trust Breast Unit Family History Clinic

Princess Alexandra Hospitals NHS Trust Breast Family History Clinic Background Overview of cancer genetics Referral Risk assessment The Family History appointment The Genetics appointment Risk-Reducing surgery Drawing a pedigree Examples and group work!!!

Background 1 in 9 women get breast cancer (Chalmers et al 2003) 5% BRCA 1/2 TP53 (Grande et al 2002) Familial Breast Cancer - 20% (Agnantis 2003) The general population is becoming increasingly aware of and concerned with their family history and it’s impact on their health. Women frequently over-estimate their risk (Martin % Degner 2006)

Lifetime Cancer Risks BRCA1Breast 80-85% Ovarian 44-60% Male Breast <1% Prostate6% BRCA2Breast 80-85% Ovarian15-20% Male Breast 8% Prostate15%

Princess Alexandra Hospitals NHS Trust Breast Family History Clinic Family history patients seen in symptomatic breast clinics NICE Guidelines 2006 Quest Charitable Trust £52K St. Margaret’s Family History clinic opened in 2006

Princess Alexandra Hospitals NHS Trust Breast Family History Clinic April 2009 – March 2010 Primarypop risk94 Secondarymod risk177 Tertiaryhigh risk324 Mammograms394 USS13 MRI19 Genetics165 New BRCA1/23 Breast cancers diagnosed3

Referral Patients referred by GP Surgeon/Oncologist Breast Care Nurse Genetics Counsellor

Referral Questionnaire NICE Guidelines Primary Secondary Tertiary

Referral Criteria Questionnaire NICE Guidelines Primary Secondary Tertiary

Primary Care – Population Risk Written information –Breast Awareness –NICE Guidelines –Pedigree Contact Details

Risk Assessment “Risk assessment is the first step in the process of providing information and support to patients and their families”(Silvell et al 2009)

NICE GUIDELINES All relatives on same side of family First Degree (FDR) – parent, full sibling, child Second Degree(SDR) – aunt/uncle, niece/nephew, half-sibling, grandparent/child Third Degree – great grandparent/child, great aunt/uncle, cousin

NICE GUIDELINES- Secondary 1 FDR Breast Cancer (BC) <40 2 FDR/SDR BC(at least one must be a FDR) 3 or more FDR/SDR BC 1 Male FDR BC 1 FDR bilateral BC 1 FDR/SDR Ovarian Cancer & 1 FDR/SDR BC (one must be a FDR) Any less than this and the patient falls into the Primary care Group

NICE GUIDELINES - Tertiary Breast Cancer 2 FDR/SDR* BC < 50 3 FDR/SDR* BC < 60 4 or more FDR/SDR* BC *one must be FDR

NICE GUIDELINES - Tertiary Ovarian Cancer 1 OC + 1 FDR BCor SDR BC <50or 1 OCor 2 FDR/SDR BC <60

NICE GUIDELINES - Tertiary Bilateral Breast Cancer 1 FDR BBC <50 1 FDR/SDR BBC + FDR/SDR BC <60

NICE GUIDELINES - Tertiary Male Breast Cancer 1 Male BC + 1 FDR/SDR BC <50or 2 FDR/SDR BC <60

Unusual Cancers Bilateral Breast Cancer Male Breast Cancer Ovarian Cancer Sarcoma <45 Glioma or childhood adrenal cortical carcinoma Complicated patterns of multiple cancers at young age

The Family History Appointment Secondary Care - moderate Risk Seen annually between ages –Mammogram –Clinical Examination –Review

The Family History Appointment Tertiary Care - high risk Referral to Genetics Counsellor Seen annually aged Then every 18 months –Mammogram if over 40 –MRI as indicated –Clinical Examination –Review

MRI Surveillance Subject to availability Annually to patients with a 10 year risk of –8% if aged –20% if aged BRCA1/BRCA2/TP53 carriers/at high risk of carrying

Risk-Reducing Surgery Bilateral Mastectomy reduces breast cancer risk by approx 90% (Hartmann et al 1999) Bilateral Salpingo-oopherectomy reduces ovarian cancer risk by approx 80% (Finch et al 2006) reduces breast cancer risk by approx 57% in BRCA 1 and 46% in BRCA 2 mutation carriers (Eisen et al 2005)

Drawing a Pedigree Taking a history –Ashkenazi Jewish Ancestry –Three generations –All cancer primaries –Age at diagnosis –Date of birth –Age at death –Any other serious illnesses/operations –? Bilateral –Male relatives –Unaffected relatives –Environmental exposure

Pedigree Symbols SB

Group Work!

Feedback!

References Agnantis,N et al (2003). Carcinogenesis of breast cancer – advances and applications Chalmers et al (2003) Reports of information and support needs of daughters and sisters of women with breast cancer. European Journal of Cancer Care, 12, Eisen,A et al (2005) Breast cancer risk following bilateral salpingo- oophorectomy in BRCA1 and BRCA2 mutation carriers: An international case-control study. Journal of clinical Oncology, Finch,A. et al (2006). Salpingo-oophorectomy and the risk of Ovarian, fallopian tube and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. Journal of the American Medical Association Grande et al (2002) Women’s views of consultations about familial risk of breast cancer in primary care. Patient education and counselling 48, Hartmann, LC et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New England Journal of Medicine NICE (2006) Women with breast cancer in the family. NICE clinical guideline 41 DoH Sivell et al (2009) Cancer genetic risk assessment for individuals at risk of afamilial breast cancer( review) The cochrane collaboration. Issue 4